MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
MTVA Key Statistics
Stock Snapshot
MetaVia(MTVA) stock is priced at $1.71, giving the company a market capitalization of 8.83M. It carries a P/E multiple of -0.28.
During the trading session on 2026-06-16, MetaVia(MTVA) shares reached a daily high of $1.71 and a low of $1.69. At a current price of $1.71, the stock is +1.1% higher than the low and still -0.0% under the high.
Trading volume for MetaVia(MTVA) stock has reached 22.71K, versus its average volume of 2.24M.
The stock's 52-week range extends from a low of $0.97 to a high of $19.03.
The stock's 52-week range extends from a low of $0.97 to a high of $19.03.
MTVA News
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on MetaVia. The associated price target remains the same with $8.00. Jason McCarthy has...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.